Biorestorative Therapies Stock Today
| BRTX Stock | USD 1.48 0.02 1.33% |
Performance0 of 100
| Odds Of DistressOver 59
|
BioRestorative Therapies is trading at 1.48 as of the 28th of November 2024; that is 1.33 percent decrease since the beginning of the trading day. The stock's open price was 1.5. BioRestorative Therapies has over 59 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. Equity ratings for BioRestorative Therapies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York. The company has 6.92 M outstanding shares of which 44.24 K shares are currently shorted by private and institutional investors with about 2.56 trading days to cover. More on BioRestorative Therapies
Moving against BioRestorative Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioRestorative Stock Highlights
| President Board | Lance Alstodt |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength | |
BioRestorative Therapies (BRTX) is traded on NASDAQ Exchange in USA. It is located in 40 Marcus Drive, Melville, NY, United States, 11747 and employs 11 people. BioRestorative Therapies is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.38 M. BioRestorative Therapies conducts business under Biotechnology sector and is part of Health Care industry. The entity has 6.92 M outstanding shares of which 44.24 K shares are currently shorted by private and institutional investors with about 2.56 trading days to cover.
BioRestorative Therapies currently holds about 17.93 M in cash with (6.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check BioRestorative Therapies Probability Of Bankruptcy
Ownership AllocationThe market capitalization of BioRestorative Therapies is $10.38 Million. BioRestorative Therapies retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check BioRestorative Ownership Details
BioRestorative Therapies Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. BioRestorative Therapies market risk premium is the additional return an investor will receive from holding BioRestorative Therapies long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.72) | |||
| Treynor Ratio | (0.05) |
BioRestorative Stock Against Markets
BioRestorative Therapies Corporate Management
| Francisco Silva | VP Scientist | Profile | |
| Robert Paccasassi | Vice Compliance | Profile | |
| Stephen Kilmer | Investor Officer | Profile | |
| Wayne MD | Clinical Board | Profile | |
| Robert Kristal | Chief Officer | Profile |
Additional Tools for BioRestorative Stock Analysis
When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.